Hydrochloric Acid

Hydrochloric Acid

SCHEMBL8533701

Cl.Cl.Cl.Cl.Cl.Cl.[Ru]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119565597-A Temperature-sensitive capsule catalyst and preparation method and application thereof 云南贵金属实验室有限公司 2025-03-07 CN disclosed
CN-116395762-B Preparation method of ruthenium hexaammine trichloride suitable for industrial production 云南弘盛铂业新材料科技有限公司 2025-02-18 CN disclosed
CN-117804529-A Composition for electrode for identifying triglyceride, working electrode, biosensor and method for detecting triglyceride 杭州安旭生物科技股份有限公司 2024-04-02 CN disclosed
CN-117512717-A Preparation method of ruthenium electroplating solution 励福(江门)环保科技股份有限公司 2024-02-06 CN disclosed
CN-114054097-B Preparation method and application of ultrathin lamellar material 广东省科学院资源利用与稀土开发研究所 2023-08-15 CN disclosed
CN-116577385-A Double-nicking enzyme driven double-free-foot DNA pedestrian biosensor and preparation method and application thereof 山东第一医科大学(山东省医学科学院) 2023-08-11 CN disclosed
CN-116395762-A Preparation method of ruthenium hexaammine trichloride suitable for industrial production 云南弘盛铂业新材料科技有限公司 2023-07-07 CN disclosed
WO-2023106244-A1 PLATINUM GROUP ELEMENT RESOURCE RECOVERY DEVICE, FILM FORMATION SYSTEM, PLATINUM GROUP ELEMENT RESOURCE RECOVERY TUBE, AND PLATINUM GROUP ELEMENT RESOURCE RECOVERY METHOD セントラル硝子株式会社 2023-06-15 WO disclosed
US-10227318-B2 Method for producing gamma-valerolactone UBE INDUSTRIES, LTD. (JP) 2019-03-12 US disclosed
US-20180297972-A1 METHOD FOR PRODUCING gamma-VALEROLACTONE UBE INDUSTRIES, LTD (JP) 2018-10-18 US disclosed
EP-3381911-A1 METHOD FOR PRODUCING -VALEROLACTONE UBE Industries, Ltd. (JP) 2018-10-03 EP disclosed
CN-106074773-A A kind of pharmaceutical composition treating diabetes constipation and preparation method thereof 济南星懿医药技术有限公司 2016-11-09 CN disclosed
CN-106075236-A Pharmaceutical composition for the treatment of diabetic nephropathy and preparation method thereof 济南星懿医药技术有限公司 2016-11-09 CN disclosed
US-9334211-B2 Hydrocracking catalyst, method for producing same, and method for producing hydroxy compound using said catalyst UBE INDUSTRIES, LTD. (JP) 2016-05-10 US disclosed
US-20140288335-A1 HYDROCRACKING CATALYST, METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING HYDROXY COMPOUND USING SAID CATALYST UBE INDUSTRIES, LTD. (JP) 2014-09-25 US disclosed
US-5783373-A THREE TYPES OF METAL COMPLEX DOPES FOR SILVER HALIDE GRAIN, GELATIN PEPTIZE, INCREASED CONTRAST EASTMAN KODAK COMPANY (US) 1998-07-21 US disclosed
US-3994868-A RUTHENIUM CATALYST MITSUBISHI CHEMICAL INDUSTRIES LTD. (JA) 1976-11-30 US disclosed